Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-15-023814
Filing Date
2015-04-29
Accepted
2015-04-29 16:11:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 127916
  Complete submission text file 0000000000-15-023814.txt   176837
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filed for) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations